2012

• Kohnke, P., Mactier, S., Almazi, J., Crossett, B., Christopherson, R. (2012), Fludarabine and Cladribine Induce Changes in Surface Proteins on Human B-Lymphoid Cell Lines Involved with Apoptosis, Cell Survival, and Antitumor Immunity. Journal of Proteome Research. 11(9), 4436-4448. [Abstract]
• Rahman, W., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Stapelberg, P., Warner, F., George, J., Bowen, D., Strasser, S., Koorey, D., Sharland, A., McCaughan, G., Shackel, N. (2012), Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver International. 32(10), 1527-1534. [Abstract]
• Leong, S., Nunez, A., Lin, M., Crossett, B., Christopherson, R., Baxter, R. (2012), iTRAQ-Based Proteomic Profiling of Breast Cancer Cell Response to Doxorubicin and TRAIL. Journal of Proteome Research. 11(7), 3561-3572. [Abstract]
• Huang, P., Giles Best, O., Belov, L., Mulligan, S., Christopherson, R. (2012), Surface profiles for sub-classification of chronic lymphocytic leukemia. Leukemia and Lymphoma. 53(6), 1046-1056. [Abstract]
• Almazi, J., Mactier, S., Best, O., Crossett, B., Mulligan, S., Christopherson, R. (2012), Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53. Proteomics - Clinical Applications. 6(5-6), 279-290. [Abstract]
• Mallawaaratchy, D., Mactier, S., Kaufman, K., Blomfield, K., Christopherson, R. (2012), The phosphoinositide 3-kinase inhibitor LY294002, decreases aminoacyl-tRNA synthetases, chaperones and glycolytic enzymes in human HT-29 colorectal cancer cells. Journal of proteomics. 75(5), 1590-9. [Abstract]
• Leong, S., McKay, M., Christopherson, R., Baxter, R. (2012), Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL. Journal of proteome research. 11(2), 1240-50. [Abstract]
• Best, O., Che, Y., Singh, N., Forsyth, C., Christopherson, R., Mulligan, S. (2012), The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease. Leukemia & Lymphoma. 53(7), 1367-1375. [Abstract]

2011

• Henrich, S., Mactier, S., Best, G., Mulligan, S., Crossett, B., Christopherson, R. (2011), Fludarabine nucleoside modulates nuclear "survival and death" proteins in resistant chronic lymphocytic leukemia cells. Nucleosides, Nucleotides and Nucleic Acids. 30(12), 1181-1189. [Abstract]
• Mactier, S., Henrich, S., Che, Y., Kohnke, P., Christopherson, R. (2011), Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma. Journal of Proteome Research. 10(3), 1030-1042. [Abstract]
• Zhou, J., Belov, L., Solomon, M., Chan, C., Clarke, S., Christopherson, R. (2011), Colorectal cancer cell surface protein profiling using an antibody microarray and fluorescence multiplexing. Journal of Visualized Experiments. 0(55), 3322. [Abstract]
• Heath, E., Kaufman, K., Christopherson, R. (2011), B-RAF: A Contributor to the Melanoma Phenotype. The international journal of biochemistry & cell biology. 43(1), 29-32. [Abstract]

2010

• Yang, F., Tay, K., Dong, L., Thorne, R., Jiang, C., Yang, E., Tseng, H., Liu, H., Christopherson, R., Hersey, P., Zhang, X. (2010), Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells. Cell Death and Differentiation. 17(8), 1354-1367. [Abstract]
• Kaufman, K., Belov, L., Huang, P., Mactier, S., Scolyer, R., Mann, G., Christopherson, R. (2010), An extended antibody microarray for surface profiling metastatic melanoma. Journal of immunological methods. 358(1-2), 23-34. [Abstract]
• Zhou, J., Belov, L., Huang, P., Shin, J., Solomon, M., Chapuis, P., Bokey, L., Chan, C., Clarke, C., Clarke, S., Christopherson, R. (2010), Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing. Journal of Immunological Methods. 355(1-2), 40-51. [Abstract]
• Cassano, J., Mactier, S., Mulligan, S., Belov, L., Huang, P., Christopherson, R. (2010), Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders. International Journal of Proteomics. 2010, 964251.
• Belov, L., Zhou, J., Christopherson, R. (2010), Cell surface markers in colorectal cancer prognosis. International journal of molecular sciences. 12(1), 78-113. [Abstract]

2009

• Kohnke, P., Mulligan, S., Christopherson, R. (2009), Membrane proteomics for leukemia classification and drug target identification. Current Opinion in Molecular Therapeutics. 11(6), 603-610. [Abstract]
• Barber, N., Gez, S., Belov, L., Mulligan, S., Woolfson, A., Christopherson, R. (2009), Profiling CD antigens on leukaemias with an antibody microarray. FEBS Letters. , 1785-1791. [Abstract]
• Langley, D., Shojaei, M., Chan, C., Lok, H., Mackay, J., Traut, T., Guss, J., Christopherson, R. (2009), Structure and Inhibition of Orotidine 5'-Monophosphate Decarboxylase from Plasmodium falciparum. Biochemistry. 48(11), 2570. [Abstract]

2008

• Ellmark, P., Högerkorp, C., Ek, S., Belov, L., Berglund, M., Rosenquist, R., Christopherson, R., Borrebaeck, C. (2008), Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays. Cancer Letters. 265(1), 98-106. [Abstract]
• Henrich, S., Gez, S., Crossett, B., Mulligan, S., Christopherson, R. (2008), Fludarabine Induces Differential Expression of Proteins in Human Leukemia and Lymphoma Cells. Nucleosides, Nucleotides & Nucleic Acids. 27(6), 634-640. [Abstract]
• Langley, D., Shojaei, M., Chan, C., Lok, H., Mackay, J., Traut, T., Guss, J., Christopherson, R. (2008), Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum. Biochemistry. 47(12), 3842-3854. [Abstract]
• Henrich, S., Christopherson, R. (2008), Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 22(0), 657-60. [Abstract]
• Barber, N., Belov, L., Christopherson, R. (2008), All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias. Leukemia research. 32(0), 315-22. [Abstract]
• Ellmark, P., Woolfson, A., Belov, L., Christopherson, R. (2008), The applicability of a cluster of differentiation monoclonal antibody microarray to the diagnosis of human disease. Methods in Molecular Biology. 439, 199-209. [Abstract]

2007

• Lee, M., Maher, M., Christopherson, R., Guss, J. (2007), Kinetic and Structural Analysis of Mutant Escherichia coli Dihydroorotases: A Flexible Loop Stabilizes the Transition State(,). Biochemistry. 46(37), 10538-50. [Abstract]
• Gez, S., Crossett, B., Christopherson, R. (2007), Differentially expressed cytosolic proteins in human leukemia and lymphoma cell lines correlate with lineages and functions. Biochimica et biophysica acta. 1774(9), 1173-83. [Abstract]
• Lee, M., Chan, C., Graham, S., Christopherson, R., Guss, J., Maher, M. (2007), Structures of Ligand-free and Inhibitor Complexes of Dihydroorotase from Escherichia coli: Implications for Loop Movement in Inhibitor Design. Journal of molecular biology. 370(5), 812-825. [Abstract]
• Henrich, S., Cordwell, S., Crossett, B., Baker, M., Christopherson, R. (2007), The nuclear proteome and DNA-binding fraction of human Raji lymphoma cells. Biochimica et biophysica acta. 1774(4), 413-432. [Abstract]
• Henrich, S., Crossett, B., Christopherson, R. (2007), Differentially expressed nuclear proteins in human CCRF-CEM, HL-60, MECA and Raji cells correlate with cellular properties. PROTEOMICS CLINICAL APPLICATIONS. 1(10), 1252-1265. [Abstract]
• Leong, S., Christopherson, R., Baxter, R. (2007), Profiling of Apoptotic Changes in Human Breast Cancer Cells Using SELDI-TOF Mass Spectrometry. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 20(5), 579-90. [Abstract]